Novartis AG | Mutual Funds

Mutual Funds that own Novartis AG

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
53,165,564
2.08%
1,618,481
0.52%
12/31/2017
Vanguard Total International Stock Index Fund
30,978,230
1.22%
494,214
0.73%
07/31/2018
American Funds Capital Income Builder
18,881,700
0.74%
333,000
1.64%
06/30/2018
CSIF Switzerland Total Market Index
15,971,506
0.63%
-81,463
14.81%
05/31/2018
Vanguard Health Care Fund
14,137,118
0.55%
0
2.34%
06/30/2018
American Funds EuroPacific Growth Fund
13,786,000
0.54%
200,000
0.8%
06/30/2018
American Funds Capital World Growth & Income Fund
13,306,000
0.52%
893,009
1.24%
06/30/2018
Dodge & Cox International Stock Fund
12,624,870
0.5%
-687,000
1.77%
06/30/2018
Vanguard Developed Markets Index Fund
12,268,680
0.48%
-9,520
0.92%
07/31/2018
Caisse de Dépôt & Placement du Québec
11,143,266
0.44%
-1,033,204
0.35%
12/31/2017

About Novartis

View Profile
Address
Lichtstrasse 35
Basel Basel-Stadt (Basle Town) 4056
Switzerland
Employees -
Website http://www.novartis.com
Updated 07/08/2019
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals.